Abstract
A randomized comparative clinical trial was conducted to investigate the possibility of decreasing the duration of treatment of acute otitis media by comparing the clinical out-come and safety of a five-day and a ten-day course of cefprozil. A total of 708 pediatric patients were enrolled in the study, 560 of whom were evaluable for efficacy. Cefprozil was found to be completely effective in 87.1 % of cases after five days of treatment, and in 91.2% after ten days of treatment. Of 19 patients with three or more previous episodes of acute otitis media, ten patients in the ten-day treatment group had a 100% cure rate, while in the five-day group four experienced cure, three improvement, and two failure. A five-day course of treatment with cefprozil can be recommended only if children have no history of recurrent acute otitis media.
Similar content being viewed by others
References
Bass JW, Cashman TM, Frostad AL, Yamaoka RM, Schooler RA, Dierdorff EP: Antimicrobials in the treatment of acute otitis media. A second clinical trial. American Journal of Diseases of Children 1973, 125: 397–403.
Strickler GB, McBean JB: The treatment of acute otitis media in children. II: A second clinical trial. Journal of the American Medical Association 1964, 187: 85–89.
van Buchem PL, Dunk JHM, van't Hof MA: Therapy of acute otitis media: myringotomy, antibiotics or neither? Lancet 1981, ii: 883–887.
Meistrup-Larsen KI, Sorensen H, Johnsen NJ, Thomsen J, Mygind N, Sedrberg-Olsen J: Two versus seven days penicillin treatment for acute otitis media. Acta Otolaryngologica 1983, 96: 99–104.
Chaput de Saintonge DM, Levine DF, Templae Savage I, Burgess GWS, Sharp J, Mayhew SR, Salder MG, Moody R, Griffiths R, Griffiths S, Meadows G: Trial of three-day and ten-day courses of amoxycillin in otitis media. British Medical Journal 1982, 284: 1078–1081.
Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD: Five versus ten days of therapy for acute otitis media. Pediatric Infectious Disease Journal 1988, 7: 14–23.
Aldrige KE, Shiro DD, Sanders CV: Comparative in vitro activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 170–172.
Scribner RK, Marks Ml, Finkhouse BD: In vitro activity of BMY-28100 against common bacteria isolated from pediatric infections. Antimicrobial Agents and Chemotherapy 1987, 31: 630–631.
Kafetzis DA: Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 857–865.
Mandel EM, Bluestone CD, Rockette HE, Blatter MM, Reisinger KS, Wucher FP, Harper J: Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin. Pediatric Infectious Disease Journal 1982, 1: 310–316.
Del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, Stull FL: Bacteriology of acute otitis media: a new perspective. Journal of Pediatrics 1992, 120: 81–84.
Bluestone CD, Stephenson JS, Martin LM: Ten-year review of otitis media pathogens. Pediatric Infectious Diseases Journal 1992, 11, Supplement: 7–11.
Coles SJ, Addlestone MB, Kamdar MK, Macklin JL: A comparative study of clarithromycin and amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Infection 1993, 21 Supplement 4: 272–278.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kafetzis, D.A., Astra, H. & Mitropoulos, L. Five-day versus ten-day treatment of acute otitis media with cefprozil. Eur. J. Clin. Microbiol. Infect. Dis. 16, 283–286 (1997). https://doi.org/10.1007/BF01695632
Issue Date:
DOI: https://doi.org/10.1007/BF01695632